Book chapter 619 views
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
The Ethical Challenges of Emerging Medical Technologies, Pages: 395 - 406
Swansea University Author: Michael McNamee
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.4324/9781003074984-33
Abstract
In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the sim...
Published in: | The Ethical Challenges of Emerging Medical Technologies |
---|---|
ISBN: | 978-100010895-8 9781003074984 |
Published: |
Routledge
2020
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa55754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2020-11-25T10:50:13Z |
---|---|
last_indexed |
2021-01-12T04:20:18Z |
id |
cronfa55754 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-01-11T12:33:05.0033684</datestamp><bib-version>v2</bib-version><id>55754</id><entry>2020-11-25</entry><title>Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?</title><swanseaauthors><author><sid>85b0b1623e55d977378622a6aab7ee6e</sid><ORCID>0000-0002-5857-909X</ORCID><firstname>Michael</firstname><surname>McNamee</surname><name>Michael McNamee</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-11-25</date><deptcode>STSC</deptcode><abstract>In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process ‘doping’. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself.</abstract><type>Book chapter</type><journal>The Ethical Challenges of Emerging Medical Technologies</journal><volume/><journalNumber/><paginationStart>395</paginationStart><paginationEnd>406</paginationEnd><publisher>Routledge</publisher><placeOfPublication/><isbnPrint>978-100010895-8</isbnPrint><isbnElectronic>9781003074984</isbnElectronic><issnPrint/><issnElectronic/><keywords/><publishedDay>11</publishedDay><publishedMonth>9</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-09-11</publishedDate><doi>10.4324/9781003074984-33</doi><url/><notes>Edited by Arthur L. Caplan, Brendan Parent</notes><college>COLLEGE NANME</college><department>Sport and Exercise Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>STSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-01-11T12:33:05.0033684</lastEdited><Created>2020-11-25T10:48:43.5745250</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences</level></path><authors><author><firstname>S.</firstname><surname>Camporesi</surname><order>1</order></author><author><firstname>Michael</firstname><surname>McNamee</surname><orcid>0000-0002-5857-909X</orcid><order>2</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2021-01-11T12:33:05.0033684 v2 55754 2020-11-25 Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? 85b0b1623e55d977378622a6aab7ee6e 0000-0002-5857-909X Michael McNamee Michael McNamee true false 2020-11-25 STSC In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process ‘doping’. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself. Book chapter The Ethical Challenges of Emerging Medical Technologies 395 406 Routledge 978-100010895-8 9781003074984 11 9 2020 2020-09-11 10.4324/9781003074984-33 Edited by Arthur L. Caplan, Brendan Parent COLLEGE NANME Sport and Exercise Sciences COLLEGE CODE STSC Swansea University 2021-01-11T12:33:05.0033684 2020-11-25T10:48:43.5745250 Faculty of Science and Engineering School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences S. Camporesi 1 Michael McNamee 0000-0002-5857-909X 2 |
title |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
spellingShingle |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? Michael McNamee |
title_short |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
title_full |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
title_fullStr |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
title_full_unstemmed |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
title_sort |
Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? |
author_id_str_mv |
85b0b1623e55d977378622a6aab7ee6e |
author_id_fullname_str_mv |
85b0b1623e55d977378622a6aab7ee6e_***_Michael McNamee |
author |
Michael McNamee |
author2 |
S. Camporesi Michael McNamee |
format |
Book chapter |
container_title |
The Ethical Challenges of Emerging Medical Technologies |
container_start_page |
395 |
publishDate |
2020 |
institution |
Swansea University |
isbn |
978-100010895-8 9781003074984 |
doi_str_mv |
10.4324/9781003074984-33 |
publisher |
Routledge |
college_str |
Faculty of Science and Engineering |
hierarchytype |
|
hierarchy_top_id |
facultyofscienceandengineering |
hierarchy_top_title |
Faculty of Science and Engineering |
hierarchy_parent_id |
facultyofscienceandengineering |
hierarchy_parent_title |
Faculty of Science and Engineering |
department_str |
School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences |
document_store_str |
0 |
active_str |
0 |
description |
In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process ‘doping’. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself. |
published_date |
2020-09-11T04:10:11Z |
_version_ |
1763753708084002816 |
score |
11.031661 |